On the other hand, it is also suggested that the downregulation of the IGF-1 (insulin-like growth factor 1) and GLP-1 (glucagon-like peptide-1) signaling pathways significantly affects the progression of ALS pathogenesis [5]. Here, IGF1 is linked to amyotrophic lateral sclerosis.